Relay Therapeutics Inc (RLAY) shares closed today at 0.5% above its 52 week low of $20.16, giving the company a market cap of $2B. The stock is currently down 33.6% year-to-date, down 63.3% over the past 12 months, and down 41.9% over the past five years. This week, the Dow Jones Industrial Average fell 1.6%, and the S&P 500 fell 3.5%.
Trading Activity
- Trading volume this week was 9.0% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.2.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
- The stock closed at 5.5% lower than its 5-day moving average, 20.7% lower than its 20-day moving average, and 33.8% lower than its 90-day moving average.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 677.4%
- The company's stock price performance over the past 12 months lags the peer average by 343.2%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
